Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
Diabetes Res Clin Pract ; 199: 110630, 2023 May.
Article in English | MEDLINE | ID: mdl-36934794

ABSTRACT

AIM: The aim of this study was to determine the prevalence of likely eating disorders and insulin misuse in a prospective cohort of adults with type 1 diabetes mellitus (T1DM) treated with insulin pump therapy. METHODS: This prospective study was held at the participants' home. The participants completed the SCOFF questionnaire as well as a question related to insulin misuse. Information about lifestyle, medical history, insulin pump and Continuous Glucose Monitoring (CGM) data were collected. RESULTS: The analysis covered 198 participants with a median age of 51 [95% CI 38; 62] years. The prevalence of likely eating disorders was 21.7% (95% CI 16.3; 28.2) in the study population and 20.6% (95% CI 14.3; 28.6) and 24.2% (95% CI 14.6; 37.0) in males and females respectively. The prevalence of insulin misuse was 39.0% (95% CI 30.8; 47.7). There was no significant difference in prevalence between males and females for likely eating disorders and insulin misuse. The analysis of CGM data revealed no factors related to glycaemic control associated with likely eating disorders. CONCLUSION: The results of this study indicate that the prevalence of likely eating disorders is high even in a middle-aged population with a T1DM and satisfactory glucose control.


Subject(s)
Diabetes Mellitus, Type 1 , Feeding and Eating Disorders , Adult , Male , Middle Aged , Female , Humans , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/epidemiology , Diabetes Mellitus, Type 1/complications , Prospective Studies , Blood Glucose Self-Monitoring/methods , Prevalence , Blood Glucose , Insulin/therapeutic use , Insulin Infusion Systems , Feeding and Eating Disorders/epidemiology , Feeding and Eating Disorders/complications , Insulin, Regular, Human/therapeutic use , Hypoglycemic Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL